Ampullary adenoma

被引:14
作者
Baron T.H. [1 ]
机构
[1] Mayo Clinic, Rochester, MN 55905
关键词
Celecoxib; Familial Adenomatous Polyposis; Endoscopic Resection; Familial Adenomatous Polyposis Patient; Syndrome Surveillance;
D O I
10.1007/s11938-008-0021-y
中图分类号
学科分类号
摘要
Ampullary adenoma is a premalignant lesion involving the major papilla and surrounding mucosa of the second duodenum. These lesions may arise sporadically or in the setting of familial adenomatous polyposis syndrome. Ampullary adenoma may be found because of symptoms, at the time of adenomatous polyposis syndrome surveillance, or incidentally when upper endoscopy is performed for other reasons. Management options include observation, local or extended surgical resection (including pancreaticoduodenectomy), and endoscopic resection. Endoscopic resection is being performed more often and involves techniques similar to those of colonoscopic polypectomy. Preventing post-endoscopic resection pancreatitis is important and can be achieved with placement of temporary pancreatic duct stents. © Springer Science+Business Media, LLC 2008.
引用
收藏
页码:96 / 102
页数:6
相关论文
共 34 条
[1]  
Hirota W.K., Zuckerman M.J., Adler D.G., Et al., ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract, Gastrointest Endosc, 63, pp. 570-580, (2006)
[2]  
Spigelman A.D., Williams C.B., Talbot I.C., Et al., Upper gastrointestinal cancer in patients with familial adenomatous polyposis, Lancet, 2, pp. 783-785, (1989)
[3]  
Attard T.M., Cuffari C., Tajouri T., Et al., Multicenter experience with upper gastrointestinal polyps in pediatric patients with familial adenomatous polyposis, Am J Gastroenterol, 99, pp. 681-686, (2004)
[4]  
Bjork J., Akerbrant H., Iselius L., Et al., Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations, Gastroenterology, 121, pp. 1127-1135, (2001)
[5]  
Kim T.U., Kim S., Lee J.W., Et al., Ampulla of Vater: Comprehensive anatomy, MR imaging of pathologic conditions, and correlation with endoscopy, Eur J Radiol, (2007)
[6]  
Chahal P., Prasad G.A., Sanderson S.O., Et al., Endoscopic resection of nonadenomatous ampullary neoplasms, J Clin Gastroenterol, 41, pp. 661-666, (2007)
[7]  
Burke C.A., Beck G.J., Church J.M., van Stolk R.U., The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program, Gastrointest Endosc, 49, pp. 358-364, (1999)
[8]  
Matsumoto T., Iida M., Nakamura S., Et al., Natural history of ampullary adenoma in familial adenomatous polyposis: Reconfirmation of benign nature during extended surveillance, Am J Gastroenterol, 95, pp. 1557-1562, (2000)
[9]  
Moozar K.L., Madlensky L., Berk T., Gallinger S., Slow progression of periampullary neoplasia in familial adenomatous polyposis, J Gastrointest Surg, 6, pp. 831-837, (2002)
[10]  
Nugent K.P., Farmer K.C., Spigelman A.D., Et al., Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis, Br J Surg, 80, pp. 1618-1619, (1993)